Navigation Links
Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
Date:5/17/2012

SAN FRANCISCO, May 17, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will showcase radiosurgery technologies for treating early-stage inoperable lung cancer and other conditions non-invasively at the 2012 International Conference of the American Thoracic Society (ATS) later this week in San Francisco. 

"We're excited about putting our technology in front of pulmonologists who may not be familiar with radiosurgery as a treatment option for early-stage, inoperable lung cancer," said Calvin Huntzinger, M.S., senior director of surgical sciences at Varian.  "Research has been accruing to show that radiosurgery can be a viable option for these patients.[1]  In addition, a major NCI-funded study is under way to see if that viability extends to high-risk operable Stage I lung cancer patients." [2]

Varian will exhibit RapidArc® Radiosurgery on its TrueBeam™ STx system at the meeting.  The technology enables clinicians to precisely target and rapidly treat tumors using finely shaped high-energy X-ray beams. Clinicians who are gaining early experience in the clinical use of RapidArc® Radiosurgery are reporting that this approach can be performed quickly and accurately in the treatment of many thoracic tumors.[3],[4],[5],[6]

The TrueBeam STx system was engineered to enable precise, efficient treatment, two to eight times faster than other radiosurgery machines.  A high-definition multileaf collimator, or beam-shaping device, shapes the dose so that it closely matches the shape of the targeted tumor to minimize exposure of delicate healthy lung tissues and of other nearby organs, such as the heart or spinal cord.

"Radiosurgery procedures in the body have been made possible by a fairly recent convergence of technological innovations that enable precise beam shaping, real-time image guidance, and motion management
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... --  Auxilium Pharmaceuticals , Inc. (NASDAQ: AUXL ... that the Company will release results for the second ... the opening of the U.S. financial markets. The Company ... 8:30 a.m. ET to discuss results and highlights of ... be used during the call will be available on ...
(Date:7/31/2014)... , July 31, 2014  Decision Resources Group ... market intelligence product Marketrack to now include ChinaTrack; the ... device landscape in an interactive dashboard providing detailed brand-level ... volumes at a hospital level. Other key ... Updated data feed: In addition to end-user surveys of ...
(Date:7/31/2014)... 31, 2014 Hovione today announced that ... has successfully passed a pre-approval inspection by the US Food ... by the FDA Consumer Safety Officer, Ms. Britanny Terhar ... st July and concluded on the 25 th . ... principles and guidelines of Good Manufacturing Practices (GMP) and no ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2
... Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... vice president and chief commercial officer. Mr. Palekar will be ... "Rohan has an outstanding track record of success in ... CEO of Avanir. "I am delighted that we were able ...
... On March 8, attorneys at the Arizona law firm ... for failure to pay its employees the overtime wages to ... (FLSA). The Complaint was filed in the United States District Court ... pharmaceutical reps employed in the U.S. from March 2009 until ...
Cached Medicine Technology:Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer 2Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer 3JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals 2
(Date:7/31/2014)... Hudson County, NJ (PRWEB) July 31, 2014 ... that a leading gastroenterologist, Dr. Masood Rizvi, has ... system welcomes Dr. Rizvi to the community. Hundreds ... Health Medical Group, a comprehensive network of top ... wide range of specialties. This latest acquisition represents ...
(Date:7/31/2014)... You’re having a wonderful summer—sunning, gardening, enjoying BBQs ... chills and fever, headache, stiff neck, achey joints, and a ... it could actually be the first sign of Lyme ... is greater than you might think. Until last year, it ... U.S. annually. But the Centers for Disease Control and Prevention ...
(Date:7/31/2014)... 31, 2014 Two years in the ... in-depth overview of the research behind the latest scientific ... Davis and Vesanto Melina, well-respected authorities on plant-based nutrition, ... are safe and adequate for people at all stages ... as athletes and pregnant or lactating women. , ...
(Date:7/31/2014)... 31, 2014 Most mommy blogs are ... main purpose is to attract all mothers from all ... a particular group; whether its high fashion or child ... that everything on the Internet was so segmented. “I ... a particular topic and then search Google to get ...
(Date:7/31/2014)... Many black women put concerns about their hair above ... by the U.S. Centers for Disease Control and Prevention ... United States are overweight or obese. Yet some of ... have their hair restyled or restraightened, the University of ... researchers also noted a shift toward more "low-maintenance" hairstyles, ...
Breaking Medicine News(10 mins):Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 2Health News:Feel Like You Have A Summertime 'Flu'? It Could Be Lyme Disease 3Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3Health News:Mommylish Launches Its Website 2Health News:Hairdo Trumps Exercise for Many Black Women, Study Finds 2
... ... 18 million Americans suffer from heavy snoring, but don’t realize it,s likely a tell-tale sign ... ... Americans suffer from heavy snoring, but don’t realize it may actually be a tell-tale sign ...
... 16 The 15th Annual National Ergonomics Conference ... - 20, will focus on the importance of workplace ergonomics ... topics of return on investment, the aging workforce, and safety ... offices and call centers, industrial, lab, healthcare, and uncontrolled environments ...
... It was found less effective than extended-release niacin, or ... new study raises more questions about ezetimibe (Zetia), a ... statins to lower LDL, or "bad," cholesterol. , The ... June after it was discovered that LDL-cholesterol-lowering Zetia was ...
... modern medicine finds a way to treat a medical condition, ... also have to find ways to get that treatment into ... research from North Carolina State University shows that much more ... hemophilia patients in the developing world, and that the current ...
... SINGAPORE, Nov. 16 /PRNewswire-Asia/ -- Retail sales ... in the first half of 2009 with,total consumption peaking in ... Contact Lens manufacturers. Positive sales,data showing a growth of 14% ... economic recovery that is being led by consumers spending. , ...
... of ketamine users has been published online today in ... Special K) use increasing faster than any other drug ... showing the consequences of repeated ketamine use provides valuable ... the study, researchers from University College London followed 150 ...
Cached Medicine News:Health News:Heavy Snoring Linked To Potentially Life-Threatening Conditions 2Health News:Heavy Snoring Linked To Potentially Life-Threatening Conditions 3Health News:2009 National Ergonomics Conference Opens in Las Vegas November 17 With Hundreds of Industry Leaders in Attendance 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 3Health News:Research highlights need to address hemophilia in developing world 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 2Health News:GfK Asia Reports: Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 3Health News:First ever large-scale study of ketamine users published 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: